BANK OF AMERICA CORP /DE/ - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 16 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2017$016
-87.6%
0.00%
Q1 2017$01290.00%
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q1 2017
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 276,530$5,0000.00%
IFP Advisors, Inc 95$00.00%
Certified Advisory Corp 20$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders